by qfrsolutions | Jul 17, 2017 | News
Source: Globe Newswire Fortress Biotech, Inc. (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that Columbia University...
by qfrsolutions | Jun 8, 2017 | News
Source: PR Newswire Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that Allergan’s wholly-owned subsidiary, Allergan Sales LLC agreed to acquire Keller Medical, Inc., a privately held medical device company and developer of...
by qfrsolutions | May 22, 2017 | News
Source: Business Wire Nestlé has appointed Stuart Raetzman as CEO of Nestlé Skin Health, effective immediately. “I am very pleased that Stuart will be leading Nestlé Skin Health as CEO. Nestlé’s purpose is to enhance quality of...
by qfrsolutions | May 17, 2017 | News
Source: PR Newswire ALPHAEON Corporation (www.alphaeon.com) today announced that its wholly-owned subsidiary, Evolus Inc., submitted a Biologics License Application (BLA) for DWP-450, a Botulinum toxin Type A, to the U.S. Food and Drug Administration (FDA) seeking...
by qfrsolutions | Apr 25, 2017 | News
Source: FierceBiotech Sienna Biopharmaceuticals has raised $40 million to advance its pipeline of clinical-phase aesthetic and dermatology assets. The Series B round continues the rapid rise of Sienna, which has raised $86 million and bought Creabilis since it...
